Article Information
History
- September 9, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- André F. Rendeiro1,2,
- Charles Kyriakos Vorkas3,**,
- Jan Krumsiek1,2,
- Harjot Singh3,
- Shashi Kapatia3,
- Luca Vincenzo Cappelli4,
- Maria Teresa Cacciapuoti4,
- Giorgio Inghirami4,
- Olivier Elemento1,2,Ω and
- Mirella Salvatore3,Ω
- 1Institute for Computational Biomedicine, Department of Physiology and Biophysics, Weill Cornell Medicine, New York, NY, USA
- 2Caryl and Israel Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, NY, USA
- 3Division of Infectious Diseases, Weill Cornell Medicine, New York, NY, USA
- 4Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA
- ↵ΩCo-senior authors and correspondence: ole2001{at}med.cornell.edu, mis2053{at}med.cornell.edu
Posted September 09, 2021.
Metabolic and immune markers for precise monitoring of COVID-19 severity and treatment
